# Pediatric Prospective Personalized Immune and Target Identification Trial

> **NCT04859543** · NA · COMPLETED · sponsor: **Masaryk University** · enrollment: 80 (actual)

## Conditions studied

- Central Nervous System Neoplasms
- Pediatric Cancer
- GEN1 Gene Mutation
- Tumor, Brain

## Interventions

- **DEVICE:** FoundationOneHeme

## Key facts

- **NCT ID:** NCT04859543
- **Lead sponsor:** Masaryk University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-02
- **Primary completion:** 2024-12-10
- **Final completion:** 2024-12-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04859543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04859543, "Pediatric Prospective Personalized Immune and Target Identification Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04859543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*